(Q37111848)

English

Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

cystic fibrosis

0 references

0 references

quality of life

1 reference

based on heuristic

inferred from title

author name string

Jennifer R Weiner

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Edmond L Toy

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Patricia Sacco

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Mei Sheng Duh

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

751-766

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Cystic fibrosis: an overview

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Cystic Fibrosis Adult Care

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Aerosolized antibiotics in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Savings in direct medical costs from the use of tobramycin solution for inhalation in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Cost of care and clinical condition in paediatric cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

The cost of medical care for patients with cystic fibrosis in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Validation of a Disease-Specific Measure of Health-Related Quality of Life for Children with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Health-related quality of life for adults with cystic fibrosis: a regression approach to assessing the impact of recombinant human DNase.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Living with cystic fibrosis: impact on global quality of life

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Pharmaceutical intervention in the care of cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Quality of life as a treatment outcome in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Determinants of adherence in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.5.751

21 January 2018

Identifiers

10.1517/14656566.9.5.751

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37111848&oldid=1687025604"